Recruiting Narcolepsy Type 1 Studies in Macon
About Narcolepsy Type 1 Clinical Trials in Macon
Narcolepsy type 1 is characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy), caused by loss of hypocretin-producing neurons in the brain. It affects about 1 in 2,000 people. Treatment includes stimulants, sodium oxybate, and newer orexin receptor agonists.
There are currently 2 narcolepsy type 1 clinical trials recruiting participants in Macon, GA. These studies are seeking a combined 300 participants. Research is being sponsored by Alkermes, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Type 1 Clinical Trials in Macon — FAQ
Are there narcolepsy type 1 clinical trials in Macon?
Yes, there are 2 narcolepsy type 1 clinical trials currently recruiting in Macon, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Macon?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Macon research site will contact you about next steps.
Are clinical trials in Macon free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Macon studies also compensate for your time and travel.
What narcolepsy type 1 treatments are being tested?
The 2 active trials in Macon are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy type 1.
Data updated October 15, 2026 from ClinicalTrials.gov